Most providers recommend waiting at least one week after your last injectable dose before starting oral therapy, though specific guidance should come from your prescriber
GLP-1 microdosing involves administering low doses of GLP-1 receptor agonists to support preventive health, not just diabetes or rapid weight loss
The FDA has approved several GLP-1 receptor agonists for type 2 diabetes management and, in some cases, chronic weight management
Nathan DM, Lachin JM, Bebu I et al (2022) Glycemia reduction in type 2 diabetes - microvascular and cardiovascular outcomes
These levels can also radically decrease due to surgery, infection, medications or radiation
(30) These findings suggest that semaglutide may play a role in reducing surgical-site infections and improving recovery outcomes by addressing key metabolic risk factors such as obesity, hyperglycemia, and systemic inflammation